期刊
CURRENT TOPICS IN MEDICINAL CHEMISTRY
卷 5, 期 16, 页码 1697-1716出版社
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/156802605775009720
关键词
caspase inhibitor; apoptosis; ICE; VX-740; VX-765; IDN-6556; alpha-fas-induced liver model; Jurkat; peptidomimetics
Caspase inhibition has been demonstrated to be therapeutically effective in moderating excessive programmed cell death, or apoptosis. Publications detailing programs in the pharmaceutical industry have been more frequent in recent years, ranging from SAR Studies to clinically relevant animal models of disease. A summary of the work published in this exciting new area is presented, outlining the broad applicability of this fundamental cellular mechanism across several disease indications. This area of research has matured to the level of advancing compounds into clinical trials: VX-740 (Pralnacasan) and VX-765 as anti-inflammatory agents, and IDN-6556, a pan-caspase inhibitor as an anti-apoptotic agent.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据